{"data":[{"accessionNo":"0001623632-26-001548","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"J. Christopher Donahue","reportingCik":null,"personType":"IN","sharesOwned":4965414,"percentOfClass":5.06,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-001548","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Ann C. Donahue","reportingCik":null,"personType":"IN","sharesOwned":4965414,"percentOfClass":5.06,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-001548","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Thomas R. Donahue","reportingCik":null,"personType":"IN","sharesOwned":4965414,"percentOfClass":5.06,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-001548","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Voting Shares Irrevocable Trust","reportingCik":null,"personType":"OO","sharesOwned":4965414,"percentOfClass":5.06,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-001548","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"Federated Hermes, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4965414,"percentOfClass":5.06,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0000315066-26-001937","formType":"SCHEDULE 13G/A","amendmentNo":15,"issuerCik":"0001339970","issuerName":"ATYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":2471418,"percentOfClass":2.5,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0000315066-26-001937","formType":"SCHEDULE 13G/A","amendmentNo":15,"issuerCik":"0001339970","issuerName":"ATYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":2471418,"percentOfClass":2.5,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0002012383-26-002254","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":1725072,"percentOfClass":1.8,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-000980","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"J. Christopher Donahue","reportingCik":null,"personType":"IN","sharesOwned":8509678,"percentOfClass":8.68,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-000980","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Ann C. Donahue","reportingCik":null,"personType":"IN","sharesOwned":8509678,"percentOfClass":8.68,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-000980","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Thomas R. Donahue","reportingCik":null,"personType":"IN","sharesOwned":8509678,"percentOfClass":8.68,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-000980","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Voting Shares Irrevocable Trust","reportingCik":null,"personType":"OO","sharesOwned":8509678,"percentOfClass":8.68,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-26-000980","formType":"SCHEDULE 13G/A","amendmentNo":11,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Federated Hermes, Inc.","reportingCik":null,"personType":"HC","sharesOwned":8509678,"percentOfClass":8.68,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0000315066-26-001409","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001339970","issuerName":"ATYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-05-29","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":5935900,"percentOfClass":6.1,"filedAt":"2026-06-05","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0000315066-26-001409","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001339970","issuerName":"ATYR PHARMA INC","ticker":"ATYR","cusip":"002120202","securityClass":"COMMON STOCK","eventDate":"2026-05-29","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":5935900,"percentOfClass":6.1,"filedAt":"2026-06-05","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0000102909-26-000733","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001339970","issuerName":"aTyr Pharma Inc","ticker":"ATYR","cusip":"002120202","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-25-001385","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Federated Hermes, Inc.","reportingCik":null,"personType":"HC","sharesOwned":10544437,"percentOfClass":10.76,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-25-001385","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Voting Shares Irrevocable Trust","reportingCik":null,"personType":"OO","sharesOwned":10544437,"percentOfClass":10.76,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-25-001385","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Thomas R. Donahue","reportingCik":null,"personType":"IN","sharesOwned":10544437,"percentOfClass":10.76,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-25-001385","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Ann C. Donahue","reportingCik":null,"personType":"IN","sharesOwned":10544437,"percentOfClass":10.76,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"},{"accessionNo":"0001623632-25-001385","formType":"SCHEDULE 13G/A","amendmentNo":10,"issuerCik":"0001339970","issuerName":"aTYR PHARMA INC","ticker":"ATYR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"J. Christopher Donahue","reportingCik":null,"personType":"IN","sharesOwned":10544437,"percentOfClass":10.76,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/atyr"}],"updatedAt":"2026-11-03T23:28:52.370Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/atyr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}